SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 26.62 EUR 1.53% Market Closed
Market Cap: 4B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCHOTT Pharma AG & Co KgaA
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Cash from Operating Activities
€181.7m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Cash from Operating Activities
-€34.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gerresheimer AG
XETRA:GXI
Cash from Operating Activities
€255.9m
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
6%
No Stocks Found

SCHOTT Pharma AG & Co KgaA
Glance View

Market Cap
4B EUR
Industry
Life Sciences Tools & Services

SCHOTT Pharma AG & Co KgaA is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Mainz, Hessen. The company went IPO on 2023-09-28. SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The firm's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.

1SXP Intrinsic Value
34.05 EUR
Undervaluation 22%
Intrinsic Value
Price

See Also

What is SCHOTT Pharma AG & Co KgaA's Cash from Operating Activities?
Cash from Operating Activities
181.7m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Cash from Operating Activities amounts to 181.7m EUR.

What is SCHOTT Pharma AG & Co KgaA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
20%

Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for SCHOTT Pharma AG & Co KgaA have been 20% over the past three years .

Back to Top